Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

Subjects with preexisting cardiovascular conditions who were receiving long-term sibutramine treatment had an increased risk ofNonfatal myocardial infarction and nonfatal stroke but not of cardiovascular death or death from any cause.